Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
IOVA
Stock Latest News
The Fly
Iovance Biotherapeutics files automatic mixed securities shelf
9d ago
IOVA
Premium
Company Announcements
Iovance Shareholders Approve Expanded Capital Flexibility and Governance
17d ago
8K
IOVA
Premium
Ratings
Joseph Pantginis Maintains Buy Rating on Iovance as AMTAGVI’s Global Expansion and Survival Data Support Unchanged $9 Price Target
23d ago
IOVA
Premium
The Fly
Iovance receives Australian approval of Amtagvi for advanced melanoma
24d ago
IOVA
Premium
The Fly
Iovance gets allowance to proceed from FDA for IOV-5001 IND application
26d ago
IOVA
Premium
Company Announcements
Iovance’s Terminated TIL Study Reshapes Expectations for Solid-Tumor Growth
1M ago
IOVA
Premium
Company Announcements
Iovance Biotherapeutics Signals Strong Momentum in Call
2M ago
IOVA
Premium
The Fly
Iovance Biotherapeutics price target lowered to $14 from $16 at Chardan
2M ago
IOVA
Premium
The Fly
Iovance Biotherapeutics reports Q1 EPS (19c), consensus (15c)
2M ago
IOVA
Premium
The Fly
Iovance Biotherapeutics sees Q2 revenue $86M-$88M, consensus $84.36M
2M ago
IOVA
Premium
The Fly
Iovance Biotherapeutics sees FY26 revenue $350M-$370M, consensus $359.68M
2M ago
IOVA
Premium
The Fly
Unusually active option classes on open May 6th
2M ago
AG
DIS
Premium
Pre-Earnings
Iovance Biotherapeutics (IOVA) Q1 Earnings Cheat Sheet
2M ago
IOVA
Premium
The Fly
Replimune CRL positive for Iovance in near-term, says Chardan
3M ago
IOVA
REPL
Premium
The Fly
Iovance could advance 5%-15% on Replimune rejection, says Jefferies
3M ago
IOVA
REPL
Premium
The Fly
Unusually active option classes on open April 10th
3M ago
AMC
AMD
Premium
Company Announcements
Iovance Biotherapeutics Announces Upcoming Board Member Retirement
3M ago
8K
IOVA
Premium
The Fly
Iovance Biotherapeutics call volume above normal and directionally bullish
4M ago
IOVA
Premium
The Fly
Iovance Biotherapeutics price target raised to $4 from $2 at UBS
4M ago
IOVA
Premium
Company Announcements
Iovance Biotherapeutics Signals Strong Momentum In Earnings
4M ago
IOVA
Premium
The Fly
Iovance Biotherapeutics price target raised to $4 from $3 at Baird
4M ago
IOVA
Premium
The Fly
Iovance Biotherapeutics price target raised to $11 from $10 at Barclays
4M ago
IOVA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
